Both nuclease P1 treatment and reverse-phase high-performance liquid chromatography (HPLC) were used to enrich hydrophobic/bulky DNA adducts in DNA digests. 32P-postlabeling procedures and thin layer chromatography were then used to detect and quantitate aromatic/bulky DNA adducts. For both human and fish DNA from individuals exposed to environmental carcinogens, the nuclease PI and HPLC enrichment procedures generally gave similar results. The bottom sediments of the Buffalo and Detroit rivers are contaminated with polycyclic aromatic hydrocarbon carcinogens, and brown bullheads in these rivers show a high rate of liver cancer. Compared to DNA from control fish raised in aquariums, DNA of livers of brown bullheads from the polluted rivers exhibited elevated levels of DNA adducts. DNA from human oral mucosal cells and lymphocytes exhibited DNA adducts, but adducts levels did not differ significantly in smokers and nonsmokers. Adduct levels in DNA from human lung biopsy tissue, however, were elevated in smokers compared to nonsmokers. In former smokers, adducts levels were highest in those who had recently quit, and lowest in those who had not smoked for 10 years or more. Measurement of DNA adducts by 32P-postlabeling appears to be a useful and particularly direct procedure for assessing genetic damage from environmental carcinogens.
INTRODUCTION
OST CHEMICAL CARCINOGENS APPEAR to be genotoxic. and act via the covalent binding of M either the carcinogen itself or its electrophilic metabolites to DNA. Figure 1 shows the central position of DNA adducts in the chain of events leading from the initial presence of a carcinogen in the environment to eventual production of metastatic cancer.
The formation of DNA adducts is the end result of a multistage process that begins with the entry of bioavailable carcinogen into the body and its distribution to different organs and tissues. This process is characterized by things that happen to the carcinogen. Most carcinogens are actively metabolized, with metabolism leading either to the detoxification and excretion of the carcinogen or to the formation of reactive electrophilic metabolites that can form covalent adducts with cellular macromolecules, including DNA. Newly formed DNA-carcinogen adducts The presence of DNA-carcinogen adducts in a given tissue is, in turn, the beginning of a multistage process which may lead to cancer. This latter process is characterized by things that happen to genetically damaged cells. If a cell contains DNA that has been adducted or otherwise damaged by a carcinogen and the cell attempts to divide, heritable DNA mutations may occur when the cell attempts to use carcinogen-damaged DNA as a template. The frequency of such mutations may be increased by cytotoxic agents that cause cell death and thus stimulate cell turnover. Tumor promoters may also stimulate cell turnover, or may be involved in the production of second genetic events. Immunosurveillance may have a critical role in the survival frequency of initiated neoplastic foci. The eventual appearance of a clinically significant tumor will depend on tumor progression and perhaps metastasis, as modified by immune surveillance.
Levels of DNA-carcinogen adducts in an organism are a function of the level of an environmental carcinogen. This relationship, however, is modified by the efficiency of the various stages that intervene between the environment and the DNA (Fig. 1 , events between top and middle levels). Since DNA damage is critical in the formation of genetically altered cells that can progress to malignancy, the level of DNA adducts in a tissue is a highly relevant internal dosimeter of the effective biological dose of a carcinogen. In laboratory experiments, agents or protocols that alter the stages between the environmental carcinogen and the production of DNA adducts tend to alter adduct levels and tumor yields in parallel. (2) The use of adducts as an aid in estimating the internal dosage of carcinogens has recently been reviewed by a number of authors.(3-7) Traditional laboratory experiments for investigating adduct formation have used radioactively labeled carcinogens. A variety of new techniques have recently been developed that for the first time have allowed the measurement of adducts in animal and humans exposed to nonlabeled environmental carcinogens.@) The major approaches involve the measurement of adducts by their native fluorescence, the use of immunoassays,@) or the postlabeling of adducts by 32P. (8, 9) 
DNA ADDUCTS IN HUMAN AND FISH TISSUES
We have used 32P-postlabeling assays to measure aromatic DNA-carcinogen adducts in both humans and animals exposed to environmental carcinogens.(lO-'?) This assay can detect adducts with a sensitivity of 1 nmole adduct/mole normal nucleotide or better, using samples of DNA of less than 10 pg, We present here an overview of our work to date with the postlabeling assay, and discuss some issues related to the interpretation of data from the assay.
METHODS AND MATERIALS
Tissues were analyzed for DNA adducts using the nuclease PI-enhanced variant of the 32P-postlabeling assay,(l3.I4) or the HPLC enrichment variant developed in our laboratory.("+) In both assays, DNA is enzymatically degraded to 3' deoxynucleotides (nucleoside 3' phosphates).
Normal nucleotides are then selectively destroyed by hydrolysis with nuclease P1, or removed by HPLC on a reverse phase column. Adducted nucleotides along with residual normal nucleotides are then radioactively labeled in the 5' deoxyribose position by 32P, using [32P]ATP and polynucleotide kinase. Selective thin-layer chromatography on PEI cellulose is then used to remove normal nucleotides and unused [32P]ATP from the samples. Finally, adducted nucleotides are resolved by further two-dimensional thin layer chromatography on PEI cellulose. Adduct spots on chromatograms are detected by autoradiography, and quantitated by scintillation counting. The procedures used are selective for the detection of adducts of aromatic and/or lipophilic carcinogens that form relatively bulky, hydrophobic adducts with DNA. The procedures respond particularly well to adducts of polycyclic aromatic hydrocarbons.
RESULTS

Characteristics of nuclease-PI-and HPLC-enhanced ~2P-postlabeling assays
We have examined a large number of human and animal DNA samples using a protocol that combines both the nuclease-P I-enchanced and the HPLC-enhanced version of the assay. For most samples, the chromatographic patterns seen were very similar for the two procedures. In less than 10% of the samples, chromatographic zones visible using one procedure were not seen when using the other. In such cases, the nuclease PI procedure was superior in about as many cases as the HPLC procedure. In practice, the sensitivity of both versions of the assay for detecting discrete spots is limited to approximately 1 nmole/mole by diffuse background radioactivity on the chromatographic plates. For human cell samples, typical aromatic adduct levels have been in the range of 10-100 nmole/mole, with only occasional samples showing levels higher than this. Similar levels have been seen in tissues from wild animals from clean environments, while levels in specimens from polluted environments have typically ranged from 100 to 1000 nmoles/mole.
For nuclease-P 1 -enhanced samples, all chromatograms contained a single "background" spot that did not vary appreciably in intensity from sample to sample. For HPLC-enriched samples, the same spot was seen along with a second background spot that was normally absent or at a much reduced intensity in nuclease-Pl-treated samples.~l4) Both background spots were seen at approximately equal levels in DNA from a large variety of vertebrate DNA sources including humans, rodents, fish, and rapidly growing tissue culture cells. When chromatographed, the 3' nucleotide precursors of the labeled spots have been shown to be very hydrophobic. (14) It is not clear if the background spots represent a normal DNA constituent, a DNA adduct of reactive molecules present in all cells, an artifact of the DNA digestion procedure, or some other unknown phenomenon.
The nuclease-P1-based postlabeling procedure is somewhat simpler than the HPLC-based procedure. However, the HPLC-based procedure is not subject to one important limitation of the nuclease P1 procedure: the inability to analyze adducts sensitive to dephosphorylation by DUNN nuclease P1. In addition, the HPLC-based procedure allows the fractionation of adducts in a given sample.cl4) Both versions of the assay are easily performed together on the same sample of digested DNA. When major nonbackground spots or zones occurring in chromatograms derived from the nuclease-P 1 -and HPLC-based procedures were quantitated, adduct levels generally agreed within a factor of 2. The demonstration of an adduct spot by postlabeling after two totally different adduct enrichment methods gives some assurance that spots seen are not artifacts of one or the other procedure.
For both assays repeat analysis of DNA samples gave results comparable to the first assay. Omission of DNA from the assays leads to the disappearance of all chromatographic spots, including the background spots discussed above. Overall, the results suggest that the nonbackground chromatographic spots seen are not artifacts of the procedures used but represent adducted nucleotides from DNA.
Adduct measurements in Jish and human cells
We have previously reported the results of 32P-postlabeling analysis of DNA from the livers of brown bullheads living in the polluted Buffalo and Detroit rivers.(lI) These fish live in an environment where the bottom sediments are heavily contaminated with polycyclic aromatic hydrocarbon carcinogens. Approximately 10% of mature fish caught in either area show liver tumors, while tumor rates from fish in unpolluted areas are generally low. When either the nuclease-P 1 -or the HPLC-enhanced postlabeling assay is used, chromatograms derived from DNA of fish from the Buffalo and Detroit rivers exhibited a diagonal radioactive zone that was not present in chromatograms derived from control fish (Fig. 2) . Experiments involving chromatography of adducted nucleotides from fish liver have indicated that the adducts are very hydrophobic.(II) Most of the material in the diagonal zone has a retention time on a reverse phase HPLC column longer than the major adduct produced in cells treated with benzo(a)pyrene. These experiments have also indicated that the diagonal zone on chromatograms consists of multiple overlapping chromatography spots. This latter finding is consistent with the zone being composed of multiple adduct species from a group of chemically related DNAreactive chemicals.
We have recently examined DNA from lung biopsies of patients undergoing bronchoscopy for diagnostic purposes.(l5) In most samples from smokers we have found a diagonal chromatographic zone similar in appearance to that seen in fish from polluted waters (Fig. 2) . This zone was absent or of low intensity in nonsmokers, and was detected using both the nuclease PI and the HPLC version of the postlabeling assay.
For fish from polluted areas and human lung biopsies from smokers, adduct levels were several times those seen in unexposed individuals. When we examined biopsies from exsmokers, we found that adduct levels were highest in those who had recently quit, and lowest in those who had abstained from cigarettes for a number of years. Substantial levels of smoking-related adducts were visible for at least several years after the cessation of smoking. It is unclear if this prolonged presence of adducts represents long-lived adducts or the continued formation of adducts from carcinogens retained in the lungs after the cessation of smoking.
We have found that by brushing the lining of the mouth with a soft toothbrush, it is easy to obtain several million oral mucosa cells. Oral cancer is associated with cigarette smoking, as well as the chewing of tobacco and betel nut. Using a early version of the 32P-postlabeling assay (not involving enrichment of adducts by nuclease P1 treatment or HPLC), we have examined cells from people with these high-risk habits.(lO) We did not find any significant association between adduct levels or patterns and the practice of chewing tobacco or betel nut, or the practice of "inverted" smoking (placing burning end of cigarette in mouth). More recently, we have used the nuclease-P1-enhanced version of the assay to reexamine adducts both in oral mucosa cells and in white blood cells of smokers and nonsmokers (unpublished data). Most samples exhibited nonbackground spots, but in an examination of smokers and nonsmokers we did not find any correlation between adduct patterns or levels and tobacco usage. In particular,
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FIG. 2.
32P-postlabeling analysis of DNA from fish liver and human lung. Liver samples were from brown bullheads. Unexposed fish were raised in clean aquariums, while exposed fish were from the Buffalo river. Unexposed human lung samples were bronchial biopsies from lifetime nonsmokers, while exposed samples were from habitual cigarette smokers. Samples were analyzed by the nuclease PI version of the 32P-postlabeling assay. Arrow heads indicate background spots. the characteristic diagonal chromatographic zone seen in DNA from the lungs of smokers and the livers of fish living in polluted areas was not generally present in blood or oral mucosa cells of smokers.
Terminology for reporting adduct levels
Adduct levels detected so far in humans and animals exposed to environmental carcinogens have generally ranged from approximately 1 nmole to 1 pmole adduct/mole of normal nucleotide. Values reported in the literature, however, may use a large variety of different units, resulting in difficulties in easily comparing one study to another. To aid in the comparison of data from different sources, we have developed a simple nomogram (Fig. 3) .
Column A indicates the relative molar abundance of adducts and normal nucleotides in DNA. Some research groups report the results of postlabeling in terms of relative adduct labeling, (RAL). When the postlabeling reaction is carried out to completion and normal and adducted nucleotides are fully labelled, RAL is numerically equivalent to the values in column A. However, when postlabeling is performed using conditions that selectively label adducts, RAL values may be higher than the actual adduct abundance.(l) Columns B-E illustrate different methods of expressing the molar ratio of adducts to normal nucleotides. In our own work, we have favored the use of data expressed in nmoles adduct/mole normal nucleotide (column B) because this gives simple nondecimal, nonexponential numbers from 1 to 1000 for adduct levels in the range of interest. Columns F and G indicate the units used in a second major system for reporting adduct values, in which moles of adduct are reported per unit weight of DNA. These units are most frequently used in reporting the results of immunoassays for carcinogens in DNA. However, they have also been used for other assays in which the DNA introduced into an assay is measured by its weight but the adducts associated with the DNA are measured in moles. Although it is widely used, this system of units is somewhat inconvenient. Since adducts and DNA are not measured using the same units (moles vs. grams), the relative abundance of adducts and normal nucleotides is not immediately evident. Furthermore, many research groups use units such as fmole/pg which further complicate numerical values by incorporating an unreduced fraction into each measurement (units of [10] [11] [12] [13] [14] [15] in the numerator and 10-6 in the denominator).
Column G indicates the relative molar abundance of adducts and guanine in DNA. This system is generally used by laboratories investigating guanine adducts formed by alkylating agents. Since guanine typically represents about 20% of DNA bases in vertebrates, adduct values reported using this system are approximately five times higher than if they were reported on a total adduct basis. Thus 1 pmole adduct/mole total nucleotides (column E) is equivalent to 5 pmole adduct/mole guanine (column H).
DISCUSSION
An important limitation of 32P-postlabeling procedures is their inability to give direct information that would allow for the identification of unknown chromatography spots. This does not generally matter for laboratory experiments in which the identity of the carcinogen is known. However, for field experiments it is likely to be difficult to prove that a spot or zone seen in chromatograms comes from one carcinogen or another. It would be useful to elute adduct spots from chromatograms, and use gas chromatography/mass spectrometry or related techniques to identify the adduct. However, absolute adduct levels on chromatograms are very low, with typical chromatographic spots representing between 1O-I6 and lO-I8 moles of material. Furthermore, adducts eluted from chromatograms are likely to be mixed with a complex mixture of organic materials derived from the chromatography plates, solvents, and other reagents used in the assay. Given the low levels and impurity of adducts that can be eluted from plates, no currently available analytical techniques can give direct confirmation of the identity of chromatographic spots.
Indirect information on the identity of spots is, however, available using cochromatography methods with DNA adducted with known carcinogens. If reference and unknown spots cochromatograph in several solvent systems, it is likely that they are identical. Such evidence, however, is not conclusive, since the possibility remains that the cochromatography is simply a coincidence. On the other hand, if spots from unknown and reference compounds do not cochromatograph, this is very strong evidence that the relevant adducts are different. In summary, cochromatography cannot prove that a given adduct spot does result from a given carcinogen, but can prove that the spot does nof result from the carcinogen.
Using 32P-postlabeling analysis, we have detected an exposure-related DNA-adduct zone in chromatograms derived from DNA from fish liver and from human lung tissue. The adduct zone appears to be comprised of multiple overlapping adduct spots. The chromatographic properties of the adducts indicate that they are hydrophobic and most probably aromatic. Finally, their resistance to nuclease PI suggests that the adducts are suficiently bulky that they no longer have access to the active site of this enzyme. Fish from polluted waters and human smokers are both exposed to polycyclic aromatic hydrocarbon carcinogens. The enzymatic and chromatographic behavior of the adducts from exposed fish and humans is consistent with the possibility that polycyclic aromatic hydrocarbons are responsible for the adduct zones. Further research is needed to confirm or refute this identification, and to clarify whether the adducts seen are causally related to liver and lung cancer or are merely markers of exposure to environmental contamination.
